GAG is commonly found in natural non-K12 E. coli isolates [19, 20]. Mutations

in rpoS have also been identified in Shiga-like toxin-producing E. coli strains [21]. Polymorphism of rpoS appears to be paradoxical to the central role that RpoS plays in survival. Mutants of rpoS can be selected under LGX818 mw nutrient limitation and exhibit enhanced metabolic potential [22], suggesting a regulatory trade-off for fitness between stress resistance and nutrient scavenging [22]. Growth on weak acids, including succinate [23] and acetate [24], strongly selects for mutations in rpoS in laboratory E. coli strains [23]. Considering that the weak acid (e.g., acetate) concentration is relatively high in human colon (80 mM) where E. coli colonize [25, 26], E. coli may face a similar selective pressure within the host environment. Selection for loss and gain of RpoS function may be an important adaptive mechanism, like phase variation, to ensure that E. coli can survive in CCI-779 complex natural environments. However, whether this selection is responsible for the observed rpoS polymorphism in natural E. coli isolates remains unclear, primarily because most studies have been

done with laboratory E. coli K12 strains. The genomes of E. coli isolates differ substantially and constitute a pangenome consisting of 13,000 genes, of which 2,200 genes are Tariquidar mw conserved among all isolates [27]. Since RpoS mostly controls expression of genes encoding non-essential functions [8, 9, 12, 13], RpoS likely plays a considerable role in the expression of non-conserved genes in the pangenome. Given that E. coli K12 strains only possess about 1/3 of all genes found in the pangenome of E. coli [27], it is possible that rpoS selection is limited to laboratory strains. Interestingly, selection for rpoS could

not be observed in a natural E. coli isolate ECOR10 under nutrient limitation (see Fig 5 in [22]). In this study, we wished to address three outstanding questions. First, can rpoS mutants be selected in clinical strains isolated from natural environments? Of particular interest is whether this selection occurs in pathogenic strains, which may have important medical relevance because of the potential role of RpoS in bacterial pathogenesis. Second, are there other Idelalisib clinical trial factors involved in the selection for enhanced metabolic abilities in natural strains? Finally, is there any evidence that this selection occurs in natural environments? To address these questions, we employed a succinate selection strategy as a tool [23] and examined the selection using a group of ten representative verocytotoxin-producing E. coli (VTEC) strains from all five identified seropathotypes as our model strains. VTEC strains, including the O157:H7 serotype, are responsible for most E. coli foodborne outbreaks and can cause severe diseases, including diarrhea, hemorrhagic colitis and the hemolytic uremic syndrome [28].